| Market Cap (cr): | ₹78.7 Cr | Book Value: | ₹50.8 |
|---|---|---|---|
| Lot Size: | 100 shares | 52 Week High: | ₹350 |
| 52 Week Low: | ₹163 | EPS: | ₹15.6 |
| Demat Account: | Required | PB: | 4.25 |
| Face Value: | ₹10 | Debt To Equity: | 0.06 |
| No Of Shares: | 36,42,000 | Url: |
Overview :
Company Overview
Merind Limited, founded in 1958, is a legacy pharmaceutical and APIs (Active Pharmaceutical Ingredients) company headquartered in Mumbai. Now a privately held entity after delisting in 2005 (via amalgamation), Merind has a strong track record in key pharma sectors, consistently posting robust profit margins and maintaining a stable balance sheet. The company stands out for its experience in formulation and generics manufacturing, lean operations, and focus on capital stewardship—making it a unique long-term value play in India’s pharma ecosystem.
Board of Directors
| Name | Designation |
|---|---|
| Huzaifa Habil Khorakiwala | Director |
| Zahabiya Habil Khorakiwala | Director |
| Stephen Sabbas D’souza | Director |
Company Incorporation Details
| Attribute | Details |
|---|---|
| Company Name | Merind Limited |
| CIN | U24239MH1958PLC011204 |
| Date of Incorporation | 4 November 1958 |
| Registered Office | Readymoney Terrace, 2nd Floor, Room 5, 167 Dr. Annie Besant Road, Mumbai – 400018, Maharashtra |
| Face Value | ₹10 |
| ISIN | INE215A01016 |
| Lot Size | 100 shares |
| Demat Account | Mandatory |
Shareholding Pattern (FY2025)
| Category | % Holding |
|---|---|
| Promoter (Dartmour Holdings Pvt Ltd) | 96.06 |
| Public/Other Shareholders | 3.94 |
Sector
- Industry: Pharmaceuticals
- Segment: APIs, Formulations, Heritage Generics
Why Choose Arms Securities?
Trade Merind Limited unlisted shares with confidence—benefiting from transparent pricing, regulatory safety, and true end-to-end support powered by Arms Securities.
Net Sales (in cr.)
Total Income (in cr.)
Operating Profit (in cr.)
Net Profit (in cr.)
Shareholder Funds (in cr.)
Total Assets (in cr.)
Frequently Ask Question
Have Your Any Question?
Connect with Arms Securities for live quotes, then use a demat account for SEBI-compliant, fully documented settlement.
Submit your Delivery Instruction Slip (DIS) for demat-to-demat transfer; Arms Securities handles the process.
For most pre-owned/secondary trades, no lock-in applies; new regulatory blocks may require up to 6 months (as per SEBI).
Exclusively through SEBI-recognized brokers such as Arms Securities for legal, transparent deals.
A DIS allows transfer of shares securely from seller’s to buyer’s demat after both parties’ approval.
Yes, if all trades are routed via compliant intermediaries and settled through recognized processes.
Short Term: slab rate if held ≤24 months. Long Term: 20% with indexation. Dividends are taxed at recipient’s slab.
Yes—SEBI regulates the process, requiring KYC, contract notes, and demat-based settlement.
From promoters, strategic holders, or prior investors who hold in demat (with full compliance diligence).
Subscribe for Arms Securities’ daily updates or check company filings for news.